PNPLA3 and metabolic dysfunction-associated steatohepatitis: Previous data demonstrated that during NASH, PNPLA3 tissue expression increases, from mild to severe fibrosis, and correlates with fibrosis stage and α-SMA hepatic tissue expression, independently from the PNPLA3 genotype [20].